Hugel Q3 Sales Hit KRW97.5bn as U.S. Shifts to CSO Model
Image
SEOUL – November 04, 2026 -- Hugel Inc. reported third-quarter net sales of KRW97.5 billion, with operating profit of KRW18.1 billion and net profit of KRW4.7 billion, as the South Korean aesthetics group absorbed a short-term hit from restructuring its U.S. sales model. Consolidated net sales for the first three quarters of 2026 totaled KRW352.1 billion, up 15% year-on-year.
Botulinum toxin sales fall 21% while fillers and cosmetics grow
Botulinum toxin net sales, domestic and international combined, came in at KRW47.2 billion in the third quarter, down 21% year-on-year. Hyaluronic acid (HA) dermal fillers and skinboosters rose 2% to KRW30.9 billion. Cosmetics and other businesses reached KRW19.4 billion, growing more than 25%.